Risk of suicide in men with low-risk prostate cancer

European Journal of Cancer

Volumn 49, Issue 7, 2013, Pages 1588-1599

  Carlsson, Sigrid ^a,b   Sandin, Fredrik ^c   Fall, Katja ^c   Lambe, Mats ^c,d   Adolfsson, Jan ^d   Stattin, Pär ^a,e   Bill Axelson, Anna ^f  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

Mass screening; Prostatic neoplasms; Suicide

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; PROSTATE SPECIFIC ANTIGEN; SEDATIVE AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER SCREENING; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER DATA BASE SWEDEN; RISK FACTOR; RISK REDUCTION; SOCIAL STATUS; SUICIDE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; DATABASES, FACTUAL; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; POISSON DISTRIBUTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SOCIOECONOMIC FACTORS; SUICIDE; SWEDEN; TIME FACTORS;

EID: 84876099811     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.12.018     Document Type: Article

References (26)

1. J. Hugosson, G. Aus, H. Lilja, P. Lodding, C.G. Pihl, and E.A. Pileblad Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable J Urol 169 5 2003 1720 1723 (Pubitemid 36443480)
2. A. Bill-Axelson, H. Garmo, and U. Nyberg Psychiatric treatment in men with prostate cancer-results from a Nation-wide, population-based cohort study from PCBaSe Sweden Eur J Cancer 47 14 2011 2195 2201
3. F. Fang, N.L. Keating, and L.A. Mucci Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States J Natl Cancer Inst 102 5 2010 307 314
4. A. Bill-Axelson, H. Garmo, and M. Lambe Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden Eur Urol 57 3 2010 390 395
5. K. Fall, F. Fang, and L.A. Mucci Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study PLoS Med 6 12 2009 e1000197
6. F. Fang, K. Fall, and M.A. Mittleman Suicide and cardiovascular death after a cancer diagnosis N Engl J Med 366 14 2012 1310 1318
7. M.D. Llorente, M. Burke, and G.R. Gregory Prostate cancer: a significant risk factor for late-life suicide Am J Geriatr Psychiatry 13 3 2005 195 201 (Pubitemid 41031087)
8. U. Yousaf, M.L. Christensen, G. Engholm, and H.H. Storm Suicides among Danish cancer patients 1971-1999 Br J Cancer 92 6 2005 995 1000 (Pubitemid 40546659)
9. J. Mohler, R.R. Bahnson, and B. Boston NCCN clinical practice guidelines in oncology: prostate cancer J Natl Compr Canc Netw 8 2 2010 162 200
10. P. Stattin, E. Holmberg, J.E. Johansson, L. Holmberg, J. Adolfsson, and J. Hugosson Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study J Natl Cancer Inst 102 13 2010 950 958
11. J.R. Rider, F. Sandin, O. Andren, P. Wiklund, J. Hugosson, and P. Stattin Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based Study Eur Urol 63 1 2013 88 96
12. M.R. Cooperberg, J.M. Broering, P.W. Kantoff, and P.R. Carroll Contemporary trends in low risk prostate cancer: risk assessment and treatment J Urol 178 3 Pt 2 2007 S14 S19
13. O. Bratt, A. Berglund, J. Adolfsson, J.E. Johansson, M. Tornblom, and P. Stattin Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden Scand J Urol Nephrol 44 6 2010 384 390
14. M. Van Hemelrijck, A. Wigertz, and F. Sandin Cohort profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0 Int J Epidemiol 2012 in press
15. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 1987 373 383 (Pubitemid 17055592)
16. Farmaceutiska Specialiteter i Sverige (FASS) 2012. Available from: http://www.fass.se.
17. P.C. Lambert, and P. Royston Further development of flexible parametric models for survival analysis Stata Journal 9 2009 265 290
18. R: A language and environment for statistical computing. In: R Foundation for Statistical Computing. Vienna, Austria: R Development Core Team; 2011.
19. F. Bray, J. Lortet-Tieulent, J. Ferlay, D. Forman, and A. Auvinen Prostate cancer incidence and mortality trends in 37 European countries: an overview Eur J Cancer 46 17 2010 3040 3052
20. H. Jonsson, B. Holmstrom, S.W. Duffy, and P. Stattin Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden Int J Cancer 129 8 2011 1881 1888
21. P. Stattin, H. Garmo, G. Steineck, and A. Bill-Axelson Re: immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States J Natl Cancer Inst 102 18 2010 1447 1448 author reply 1448
22. J. Hugosson, S. Carlsson, and G. Aus Mortality results from the Goteborg randomised population-based prostate-cancer screening trial Lancet Oncol 11 8 2010 725 732
23. L. Anguiano, D.K. Mayer, M.L. Piven, and D. Rosenstein A literature review of suicide in cancer patients Cancer Nurs 35 4 2012 E14 E26
24. F.H. Schroder, J. Hugosson, and M.J. Roobol Prostate-cancer mortality at 11 years of follow-up N Engl J Med 366 11 2012 981 990
25. G. Aus, S. Bergdahl, P. Lodding, H. Lilja, and J. Hugosson Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer-results from a prospective, population-based randomized controlled trial Eur Urol 51 3 2007 659 664 (Pubitemid 46110933)
26. R.C. van den Bergh, M.L. Essink-Bot, and M.J. Roobol Anxiety and distress during active surveillance for early prostate cancer Cancer 115 17 2009 3868 3878